Document:

Exhibit 10.4 SMG 2015-05-20 8-K/A

EXHIBIT 10.4
    

Commercialization and Technology Agreement
THIS COMMERCIALIZATION AND TECHNOLOGY AGREEMENT (this “Agreement”) is entered into as of this 15th day of May, 2015 (the “Effective Date”) between The Scotts Company LLC, an Ohio limited liability company, with its principal place of business at 14111 Scottslawn Road, Marysville, Ohio 43041, and Monsanto Company, a Delaware corporation, with its principal place of business at 800 N. Lindbergh Blvd., St. Louis, Missouri 63167.  

RECITALS:

		
	A.
	Whereas, the Parties are contemporaneously entering into that certain Lawn and Garden Brand Extension Agreement (the “License Agreement”) pursuant to which Monsanto shall license certain rights to Scotts within the Residential Lawn & Garden Field (as defined in the License Agreement).

		
	B.
	Whereas, Scotts wishes to receive the right, under certain circumstances, to discuss the possible acquisition of additional rights from Monsanto within the Residential Lawn & Garden Field (as defined below) and Monsanto is willing to discuss granting such rights, subject to the terms and conditions of this Agreement.  

NOW THEREFORE, in consideration of the mutual promises contained herein, the Parties agree as follows:

		
	1.
	DEFINITIONS.  Capitalized terms used herein without definition shall have the meanings assigned to them in the License Agreement.  In addition to terms defined elsewhere in this Agreement, the following terms shall have the following meanings and may be used interchangeably in the singular or plural context:

		
	1.1
	“Agency Agreement” means that certain Amended and Restated Exclusive Agency and Marketing Agreement by and between Monsanto Company and The Scotts Company LLC, effective as of September 30, 1998, and amended and restated as of November 11, 1998, and as such agreement has been amended from time to time.

		
	1.2
	 “Agricultural Uses” means the cultivation, maintenance, or harvest of plants, animals, or other organisms for the sale or other commercial use of such organisms or products made with or derived from those organisms.

		
	1.3
	“Commercialize” means offering to sell or selling a product or service for commercial purposes in combination with marketing, promotional, or advertising activities directed to selling or offering to sell such product or service.  For the avoidance of doubt, “Commercialize” does not include providing or selling a product or service for research or development purposes.  “Commercialized” and “Commercialization” shall be similarly defined.

		
	1.4
	“Controlled,” when used in connection with the term Monsanto Technology, means the ownership, contractual right, or other legal authority or right of Monsanto to, as applicable, grant a license or sublicense of rights in such Monsanto Technology to another Person, or to disclose or provide such Monsanto Technology to another Person, in either case without breaching the terms of any agreement with a Third Party. 

		
	1.5
	“Intellectual Property” means any and all:  (a) know-how, formulas, inventions, improvements, manufacturing and production processes and techniques, and other confidential, proprietary, or trade secret technical information; (b) Patents; and (c) computer software, firmware, and programs and copyrights therein and copyrights in other technical tangible works of expression.

Page 1 of 10

		
	1.6
	“ITO” means industrial, turf and ornamental.

		
	1.7
	“ITO Uses” means the use of products or services in, on, or around a property by a Person who is not the owner or a resident of the property and who has been hired, employed, or otherwise commercially engaged, directly or indirectly, by the owner or a resident of such property to use such products in, on, or around such property and services commercially applying such products.

		
	1.8
	“L&G Product” is defined in Section 2.1.

		
	1.9
	“L&G Service” is defined in Section 2.1.

		
	1.10
	“Monsanto” means Monsanto Company and its Affiliates.  

		
	1.11
	“Monsanto Technology” means Intellectual Property that is Controlled by Monsanto, determined as of the date of the applicable Technology License Notice (as defined below).  

		
	1.12
	“Party” means either Monsanto or Scotts, and the term “Parties” means collectively Monsanto and Scotts.

		
	1.13
	“Patent(s)” means (a) all patents and patent applications and any patents issuing therefrom worldwide, (b) any substitutions, divisions, continuations, continuations-in-part, reissues, renewals, registrations, confirmations, re-examinations, patents resulting from any U.S. post-grant review or inter partes review proceedings, extensions, supplementary protection certificates, term extensions (under applicable patent law or other applicable law and regulation), certificates of invention and the like, and any provisional applications of any such patents or patent application, and (c) any foreign or international equivalent of any of the foregoing.

		
	1.14
	“Professional Residential Service Uses” means the subset of ITO Uses where the Person(s) hired, employed, or otherwise commercially engaged provides services to cultivate, maintain and control lawns, gardens or plants, and to control pests associated with such lawns, gardens or plants only or substantially only to private residential customers in, on or around those residential customers’ personal residential properties (such services being “Professional Residential Services” and Persons providing such services being “Professional Residential Service Providers”).

		
	1.15
	“Related Product” means, in reference to a particular L&G Product or an L&G Service Product (as defined below), any L&G Product that is an improvement or a modification to, derived from, a derivative work of or a replacement of or in the same or similar product class or family as that L&G Product or L&G Service Product such that such L&G Product is in the same market category or accomplishes the same or similar function in the same or similar manner as that L&G Product or L&G Service Product.

		
	1.16
	“Related Product or Service” means, as applicable, and in reference to a particular L&G Product or L&G Service, a Related Product or a Related Service.

		
	1.17
	“Related Service” is defined in reference to a particular L&G Service and means, in reference to that L&G Service, any L&G Service that will use and employ, as a primary component of such L&G Service, L&G Products or Related Products as all or a majority of the L&G Products identified in respect of such L&G Service in the applicable Commercialization Notice (the “L&G Service Products”) and/or their respective Related Products. 

Page 2 of 10

		
	1.18
	“Residential Lawn & Garden Field” means (a) packaged goods marketed to, promoted or positioned solely for use by customers in, on, or around their personal residential properties to cultivate, maintain and control residential lawns, gardens, or house plants, or to control household pests or pests associated with such lawns, gardens or house plants, (b) packaged goods marketed, promoted or positioned solely for use by Professional Residential Service Providers in, on or around personal residential properties to cultivate, maintain and control residential lawns, gardens or house plants, or to control household pests or pests associated with such lawns, gardens or house plants and only when marketed, promoted and sold to consumers though DIY Superstores (i.e., stores ranging from 40,000 square feet to more than 100,000 square feet with expanded building materials with garden/landscaping centers outside of the stores such as Lowe’s and The Home Depot), and (c) Professional Residential Services provided by Professional Service Providers; but provided that notwithstanding the foregoing, the “Residential Lawn & Garden Field” excludes:

		
	(a)
	all products and services promoted or positioned for ITO Uses other than Professional Residential Service Uses; and 

		
	(b)
	all products and services promoted or positioned for Agricultural Uses.

		
	1.19
	“Scotts” means The Scotts Company LLC and its Affiliates.

		
	1.20
	“Superior Commercialization Offer” means a bona fide written offer with respect to Commercialization of an L&G Product or L&G Service, which contains terms and conditions that support a similar or alternate system of Commercialization that Monsanto determines in its reasonable discretion and taking into account all relevant legal, financial, commercial and regulatory aspects, to be more favorable to Monsanto, taken as a whole, than those set forth in the Commercialization Proposal (as defined below) provided by Scotts with respect to such L&G Product or L&G Service.  By way of example and not limitation, in making such determination, Monsanto may consider differences in the type and level of proposed services, territorial differences, Monsanto’s preference for exclusivity or non-exclusivity, the opportunity for aggregation of non-exclusive arrangements, business synergies and other commercial aspects.

		
	1.21
	“Superior License Offer” means a bona fide written offer with respect to a license of the Monsanto Technology identified in a particular Technology License Notice, which contains terms and conditions that support a similar or alternate license arrangement that Monsanto determines in its reasonable discretion and taking into account all relevant legal, financial, commercial and regulatory aspects, to be more favorable to Monsanto, taken as a whole, than those set forth in the Technology License Proposal (as defined below) provided by Scotts with respect to the license of such Monsanto Technology.  By way of example and not limitation, in making such determination, Monsanto may consider differences in the level of proposed services, territorial differences, Monsanto’s preference for exclusivity or non-exclusivity, the opportunity for aggregation of non-exclusive arrangements, business synergies and other commercial aspects.

		
	2.
	COMMERCIALIZATION AND TECHNOLOGY LICENSE OPPORTUNITIES

		
	2.1
	Commercialization.  If, during the term of this Agreement, Monsanto elects to Commercialize in the United States any product in the Residential Lawn & Garden Field (an “L&G Product”) or any services in the Residential Lawn & Garden Field that will use and employ, as the primary component of such services, any L&G Product (an “L&G Service”), then prior to engaging in such Commercialization, Monsanto shall give written notice to Scotts of such intent, which notice shall identify the L&G Product 

Page 3 of 10

or L&G Service (the “Commercialization Notice”).   Scotts shall have sixty (60) days after the date of the Commercialization Notice to provide a written proposal to Monsanto to participate in the Commercialization of such L&G Product or L&G Service (the “Commercialization Proposal”).  Any such Commercialization Proposal shall contain material terms for an agreement for such participation, including: (i) Scotts’ proposed role in such Commercialization (e.g., as a licensee, distributor, service provider, acquirer, collaborator, co-developer or other participant and whether such proposed participation role is exclusive or non-exclusive) (the “Commercialization Role”); (ii) material financial terms, including royalty payments, upfront payments, and milestone payments; (iii) the proposed term of the participation (including a description of proposed termination rights); (iv) whether any territories other than the United States are proposed for such agreement; (v) any proposed on-going service, development or other obligations Monsanto would have under such agreement; and (vi) a reasonable timeline for completing such transaction.  

		
	(a)
	If the Commercialization Proposal is not received within the sixty (60) day response period or if Scotts notifies Monsanto in writing that Scotts declines to extend such an offer, Monsanto shall thereafter have the right, without further notice or obligation to Scotts, to Commercialize (directly or via one or more Third Parties) the L&G Product or the L&G Service identified in the Commercialization Notice and/or any Related Product or Service.   Except that if, within eighteen (18) months of the end of the response period, Monsanto has not entered into an agreement with a Third Party regarding Commercialization of such L&G Product or L&G Service or Related Product or Service, then, Monsanto shall not Commercialize the L&G Product or L&G Service until Scotts has an opportunity to evaluate such L&G Product or L&G Service pursuant to this Section 2.1.

		
	(b)
	If Scotts does provide a Commercialization Proposal within the sixty (60) day response period, then Monsanto and Scotts shall have a further thirty (30) days to negotiate exclusively and in good faith the terms of Scotts’ participation in such Commercialization; provided that neither Party shall have an obligation to enter into a definitive agreement regarding a Commercialization Proposal.  If Monsanto and Scotts fail to enter into a definitive agreement for Scotts’ proposed participation in such Commercialization during such further thirty (30) day period, then, subject to Section 2.1(c) below, Monsanto shall thereafter have the right to Commercialize (directly or via one or more Third Parties) the L&G Product or the L&G Service identified in the Commercialization Notice and/or any Related Product or Related Service.  

		
	(c)
	If Scotts has timely provided a Commercialization Proposal in response to a Commercialization Notice for Commercialization of a particular L&G Product or L&G Service and the Parties have failed to enter into a definitive agreement with respect to such Commercialization within ninety (90) days of the date of the Commercialization Notice, then Monsanto may thereafter directly Commercialize the L&G Product or L&G Service and/or any Related Product or Service.  Monsanto may engage one or more Third Parties to participate in such Commercialization in any capacity other than the Commercialization Role proposed by Scotts in the applicable Commercialization Notice (or a substantially similar role) at any time or from time to time in such manner and upon such terms as Monsanto, in its discretion, deems appropriate.  In addition, Monsanto may thereafter consummate any agreement with a Third Party to participate in the Commercialization of the L&G Product or L&G Service and/or any Related Product or Service in the Commercialization Role proposed by Scotts in the applicable Commercialization Proposal if such agreement is made pursuant to the acceptance of a Superior Commercialization Offer. If an offer by such Third Party for participation in the Commercialization of the L&G Product or L&G Service and/or any Related Product or Service in the Commercialization Role proposed by Scotts 

Page 4 of 10

in the applicable Commercialization Proposal that Monsanto intends to accept is not a Superior Commercialization Offer, then Monsanto may give written notice thereof to Scotts and Scotts shall have twenty (20) days thereafter to match the terms and conditions of such offer by giving written notice to Monsanto.  If Scotts does match the terms and conditions of such offer, then Monsanto and Scotts shall, within ten (10) days thereafter, execute one or more binding agreements with respect to such transaction.  If Scotts does not match the terms and conditions of such offer or enter into such binding agreement(s) with Monsanto in such timeframe, then Monsanto may thereafter engage one or more Third Parties to participate in such Commercialization in any capacity at any time or from time to time in such manner and upon such terms as Monsanto, in its discretion, deems appropriate.

		
	(d)
	With respect to any time periods set forth in this Section, the Parties may agree to extend such periods and Monsanto’s consent to such extension shall not be unreasonably withheld, and for the avoidance of doubt, it would be reasonable to decline to grant such an extension if the extension would delay Monsanto’s planned Commercialization or its ability to negotiate with Third Parties that may have an interest in participating in Commercialization.

		
	2.2
	Technology License.  If, during the term of this Agreement, Monsanto elects to grant a license in the United States to any Third Party to any Monsanto Technology for commercial uses entirely or substantially entirely (wherein the determination of substantially entirely is based the anticipated value of such rights and Monsanto’s reasonable business judgment regarding such anticipated value) within the Residential Lawn & Garden Field, Monsanto shall give written notice to Scotts of such intent, which notice shall identify the Monsanto Technology to be licensed, the proposed commercial uses for such technology, and whether such license will be exclusive or non-exclusive (the “Technology License Notice”).   Scotts shall have sixty (60) days after the date of the Technology License Notice to provide a written proposal to Monsanto to license such Monsanto Technology from Monsanto for such commercial uses and whether such proposal is on an exclusive or non-exclusive basis (the “Technology License Proposal”).  Any such Technology License Proposal shall contain material terms for a technology license agreement including: (i) material financial terms, including royalty payments, upfront payments, and milestone payments; (ii) the proposed term of the license (including a description of proposed termination rights); (iii) whether any territories other than the United States are proposed for such agreement; (iv) any proposed on-going service, development or other obligations  Monsanto would have under such agreement; and (v) a reasonable timeline for completing such transaction.  

		
	(a)
	If the Technology License Proposal is not received within the sixty (60) day response period or if Scotts notifies Monsanto in writing that Scotts declines to extend such an offer, Monsanto shall thereafter have the right, without further notice or obligation to Scotts, to license the Monsanto Technology identified in the Technology License Notice along with any other reasonably related technology for any or all of the uses identified and on the basis (e.g., exclusive or non-exclusive) identified and reasonably related uses in the Technology License Notice.  Except that if, within eighteen (18) months of the end of the response period, Monsanto has not entered into an agreement with a Third Party regarding licensing of such Monsanto Technology or other reasonably related technology, then, Monsanto shall not license such Monsanto Technology for commercial uses entirely or substantially entirely within the Residential Lawn & Garden Field until Scotts has an opportunity to evaluate such Monsanto Technology pursuant to this Section 2.2.

		
	(b)
	If Scotts does provide a Technology License Proposal within the sixty (60) day response period, then Monsanto and Scotts shall have a further thirty (30) days to negotiate exclusively and in 

Page 5 of 10

good faith the terms of such license agreement; provided that neither Party shall have an obligation to enter into a definitive license agreement regarding a Technology License Proposal.  If Monsanto and Scotts fail to enter into a definitive license agreement during such further thirty (30) day period, then, subject to Section 2.2(c) below, Monsanto shall thereafter have the right to license the Monsanto Technology identified in the Technology License Notice along with any other reasonably related technology for any or all of the uses identified and on the basis (e.g., exclusive or non-exclusive) identified and reasonably related uses in the Technology License Notice.  

		
	(c)
	If Scotts has timely provided a Technology License Proposal in response to a Technology License Notice and the Parties have failed to enter into a definitive license agreement within ninety (90) days of the date of the Technology License Notice, then Monsanto may thereafter enter into any agreement to license the Monsanto Technology identified in the Technology License Notice along with any other reasonably related technology to a Third Party for any or all of the uses identified and reasonably related uses and on the basis (e.g., exclusive or non-exclusive) identified in the Technology License Notice if such license agreement is made pursuant to the acceptance of a Superior License Offer.  If the offer of such Third Party is not a Superior License Offer but Monsanto wishes to accept such offer, then Monsanto may give written notice thereof to Scotts and Scotts shall have twenty (20) days thereafter to match the terms and conditions of such offer by giving written notice to Monsanto.  If Scotts does match the terms and conditions of such offer, then Monsanto and Scotts shall, within ten (10) days thereafter execute one or more binding agreements with respect to such transaction.  If Scotts does not match the terms and conditions of such offer or enter into such binding agreement(s) with Monsanto in such timeframe, then Monsanto shall thereafter have the right, without further notice or obligation to Scotts, to license to one or more Third Parties the Monsanto Technology identified in the Technology License Notice along with any other reasonably related technology for any or all of the uses.

		
	(d)
	With respect to any time periods set forth in this Section, the Parties may agree to extend such time periods and Monsanto’s consent to such extension shall not be unreasonably withheld, and for the avoidance of doubt, it would be reasonable to decline to grant such an extension if the extension would delay Monsanto’s planned licensing or its ability to negotiate with Third Parties that may have an interest in participating in such licensing.

		
	2.3
	Limitations on Rights.  Nothing in this Agreement shall preclude Monsanto from: (a) pursuing or continuing any Commercialization activities in which it is engaged or committed (or which are subject to contractual obligations with respect to future commercialization with a Third Party that may preclude Scotts from having the first option under Section 2.1 and 2.2) as of the Effective Date, including any Related Product or Service, or to require Monsanto to grant Scotts the option to participate in any such activities; or (b) continuing any licensing arrangements for any Monsanto Technology in existence as of the Effective Date, including any reasonably related technology, or to require Monsanto to grant Scotts the option to license such Monsanto Technology under the same or similar terms as such existing licensing arrangements.  Furthermore, in no event shall any of the following trigger any obligations of Monsanto or rights of Scotts under this Agreement: (x) (i) any Change of Control of Monsanto or any transaction that occurs pursuant to, in connection with or arises out of such a transaction; (ii) Monsanto’s divestiture of any business, line of business, assets or investments (whether through a sale of assets or equity, merger, spin off or other similar transaction); (iii) any acquisition or investment by Monsanto of, or in, any Third Party’s business or line of business, assets, intellectual property or other rights (whether through a sale of assets or equity, merger, license, financing or other similar transaction); or (iv) any intercompany activities of Monsanto (including, without limitation, with respect to the transfer of any 

Page 6 of 10

Commercialization activities among Monsanto Company and its Affiliates); (y) activities in which a Third Party acquired by Monsanto or involved in a Change of Control of Monsanto was or is engaged at the time of such acquisition or Change of Control; or (z) the continuation of any such Third Party’s business and any related extensions thereof.  Furthermore, for the avoidance of doubt, the provisions of this Agreement shall not apply to any grant of license (or intent to grant a license) to Monsanto Technology for uses that are not entirely or substantially entirely within the Residential Lawn & Garden Field or if Monsanto does not have the legal or contractual right to enter into an agreement with Scotts.  For further avoidance of doubt, in the event of subsequent transactions with Monsanto described in 2.3(x)(iii), 2.3(y), and 2.3(z), the lack of obligations of Monsanto or rights of Scotts shall apply to L&G Product or L&G Service Commercialization activities and any technology licensing within the Residential Lawn & Garden Field in which the entity involved in such transaction, its business or assets, or any acquired business or assets are engaged in or committed to with a Third Party (or which are subject to contractual obligations with respect to future commercialization with a Third Party that may preclude Scotts from having the first option under Section 2.1 and 2.2) as of the date of such transaction (including subsequent Commercialization of Related Products and Services and licensing of any reasonably related technology), but Commercialization of other L&G Products and L&G Services and licensing of other Monsanto Technology acquired in such transaction are subject to Sections 2.1 and 2.2.

		
	2.4
	L&G Technology Showcase. Beginning in 2015 and occurring not less than once per calendar year, a Technology Review Team (hereinafter “TRT”) consisting of Monsanto and Scotts representatives shall convene, preferably in person, to review Monsanto’s pipeline of products and technologies that Monsanto deems to have potential applicability to the Residential Lawn & Garden Field and about which Monsanto is willing to discuss possible Commercialization.  The intent of the L&G Technology Showcase is to demonstrate a preferred commercialization partnership and maximize opportunities for Commercialization of L&G Products/Services.  Monsanto and Scotts shall each appoint a TRT leader to coordinate and Monsanto shall distribute a non-confidential version of the agenda in advance of the meeting, providing an abstract of the products and technologies to be discussed. At Scotts’ request, any agenda items may be removed from the agenda.

		
	3.
	TERM

		
	3.1
	The term of this Agreement shall be from the Effective Date to the thirtieth (30th) anniversary of the Effective Date, unless terminated earlier pursuant to the terms of this Agreement.  

		
	3.2
	This Agreement shall terminate immediately, without further notice or action by either Party, upon termination of the License Agreement or the Agency Agreement, in their entirety or as they apply to  any individual country or group of countries due to a material breach of either of those agreements by Scotts.  In addition, this Agreement shall terminate thirty (30) days after Scotts’ receipt of Monsanto’s written notice of Scotts’ breach of any material term of this Agreement, the License Agreement or the Agency Agreement unless Scotts cures such breach and notifies Monsanto in writing of such cure during such thirty (30) day period.  For the avoidance of doubt, (a) this Agreement may be terminated as a result of Scotts’ uncured material breach of the License Agreement or the Agency Agreement even if the License Agreement or the Agency Agreement, as applicable, is not terminated or does not terminate and (b) for purposes of this Section 3.2, a material breach of the License Agreement shall include, in addition to the Material Breaches as defined in the License Agreement, any other material breach of such agreement.

		
	4.
	ASSIGNMENT. This Agreement and the various rights and obligations arising hereunder shall inure to the benefit of and be binding upon the Parties hereto and their respective heirs, legal representatives, successors and permitted assigns.  Except as set forth in this Section 4, neither this Agreement nor any of the rights, interests or 

Page 7 of 10

obligations hereunder shall be transferred, delegated or assigned by a Party (by operation of law, Change of Control or otherwise) without the prior written consent of the other Party.  Notwithstanding the foregoing, (i) Monsanto Company shall have the right to transfer and assign all, but not less than all, of Monsanto’s rights, interests and obligations hereunder to any of its Affiliates; provided, that Monsanto Company shall remain liable for the performance of Monsanto’s obligations hereunder, and provided, further, that any such Affiliate shall be subject to the provisions of this Agreement as if it were the original party hereto, including, without limitation, this Section 4; (ii) The Scotts Company LLC shall have the right to transfer and assign all, but not less than all, of Scotts’ rights, interests and obligations hereunder to any of its Affiliates; provided, that The Scotts Company LLC shall remain liable for the performance of Scotts’ obligations hereunder, and provided, further, that any such Affiliate shall be subject to the provisions of this Agreement as if it were the original party hereto, including, without limitation, this Section 4; and (iii) The Scotts Company LLC shall be entitled to transfer and assign all, but not less than all, of Scotts’ rights, interests and obligations hereunder to (A) any Third Party to whom The Scotts Company LLC or any of its Affiliates transfers and assigns (or has previously transferred and assigned) all, but not less than all, of Scotts’ rights, interests and obligations under the Agency Agreement and the License Agreement (by operation of law, Change of Control or otherwise) as expressly permitted by the terms of such agreements or (B) any Third Party to whom The Scotts Company LLC or any of its Affiliates transfers and assigns (or has previously transferred and assigned) all, but not less than all, of Scotts’ rights, interests and obligations under the Agency Agreement and the License Agreement with respect to the North America Territories as expressly permitted by the terms of such agreements.  For the avoidance of doubt, this Agreement and the rights, interests and obligations hereunder may only be transferred and assigned (by operation of law, Change of Control or otherwise) to another party in their entirety and not in part.  

		
	5.
	REPRESENTATIONS AND WARRANTIES 

		
	5.1
	SCOTTS’ REPRESENTATION AND WARRANTIES:

		
	5.1.1
	The Scotts Company LLC is a limited liability company duly organized, validly existing and in good standing under the laws of the state of Ohio and has all requisite company power and authority to carry on and conduct its business as it is now being conducted.  

		
	5.1.2
	The Scotts Company LLC has the company power and authority to execute and deliver this Agreement, to perform its obligations hereunder, to obligate its Affiliates to perform hereunder and to consummate the transactions contemplated hereby.  The execution, delivery and performance of this Agreement and the consummation of the transactions contemplated hereby have been duly authorized, approved and ratified by all necessary action on the part of The Scotts Company LLC.  This Agreement is a legal, valid and binding obligation of Scotts enforceable in accordance with its terms.  

		
	5.1.3
	Neither the execution and delivery of this Agreement nor the consummation of the transactions contemplated hereby will (i) contravene, conflict with or result in a violation of any applicable Laws; (ii) conflict with any of the provisions of The Scotts Company LLC’s organizational documents; (iii) violate in any material respect the terms of any other material agreement, contract or other instrument to which The Scotts Company LLC is a party; or (iv) give rise to any consent or authorization of any other Person.

Page 8 of 10

		
	5.2
	MONSANTO’S REPRESENTATION AND WARRANTIES:

		
	5.2.1
	Monsanto Company is a corporation duly organized, validly existing and in good standing under the laws of the state of Delaware and has all requisite corporate power and authority to carry on and conduct its business as it is now being conducted.  

		
	5.2.2
	Monsanto Company has the corporate power and authority to execute and deliver this Agreement, to perform its obligations hereunder, to obligate its Affiliates to perform hereunder and to consummate the transactions contemplated hereby.  The execution, delivery and performance of this Agreement and the consummation of the transactions contemplated hereby have been duly authorized, approved and ratified by all necessary action on the part of Monsanto Company.  This Agreement is a legal, valid and binding obligation of Monsanto, enforceable in accordance with its terms.  

		
	5.2.3
	Neither the execution and delivery of this Agreement nor the consummation of the transactions contemplated hereby will (i) contravene, conflict with or result in a violation of any applicable Laws; (ii) conflict with any of the provisions of Monsanto Company’s organizational documents; (iii) violate in any material respect the terms of any other material agreement, contract or other instrument to which Monsanto Company is a party; or (iv) give rise to any consent or authorization of any other Person.

		
	6.
	DISPUTE RESOLUTION.  The Parties agree to resolve any disputes that may arise from time to time in connection with this Agreement in connection with the dispute resolution procedures set forth in Section 16 of the License Agreement; provided, however, that no breach or alleged breach of this Agreement shall be deemed to be a Material Breach for purposes of Section 16.4 of the License Agreement.    

		
	7.
	CONFIDENTIALITY.  The provisions of Section 17 of the License Agreement shall apply to and govern any Confidential Information disclosed by a “disclosing” Party to a “receiving” Party in connection with their obligations under this Agreement.  However, if Monsanto reasonably requests additional confidentiality undertakings in connection with any proposed Commercialization Notice or Technology License Notice, and Scotts declines to enter into such additional confidentiality undertakings, then Monsanto shall have no obligation to Scotts with regard to any such proposed Commercialization Notice or Technology License Notice.

		
	8.
	NOTICES.  All notices, requests, approvals, disapprovals, consents and statements to be given hereunder shall be given or made in accordance with the notice provisions in Section 18 of the License Agreement.

		
	9.
	NO WAIVER: MODIFICATION: SEVERABILITY.  None of the terms of this Agreement can be waived or modified except expressly in writing signed by both Parties.  The failure of either Party to insist on compliance with any provision hereof shall not constitute a waiver or modification of such provision or any other provision.  If any provision hereof is held to be invalid or unenforceable by any court of competent jurisdiction or any other authority vested with jurisdiction, such holding shall not affect the validity or enforceability of any other provision hereto.

		
	10.
	WHOLE AGREEMENT: CONSTRUCTION.  Upon execution, this Agreement cancels, terminates and supersedes any prior Agreement or understanding relating to the subject matter hereof between Monsanto and Scotts.  This Agreement includes the entire understanding between the Parties as to its subject matter, and there are no representations, promises, warranties, covenants, or undertakings other than those contained herein.  

Page 9 of 10

		
	11.
	GOVERNING LAW.  The governing law and venue provisions of Section 23 of the License Agreement shall apply to this Agreement.

		
	12.
	SURVIVABILITY.  The respective obligations of the Parties under this Agreement, which by their nature would continue beyond the termination, cancellation or expiration of this Agreement shall survive the Agreement’s termination, cancellation or expiration.

		
	13.
	MISCELLANEOUS

		
	13.1
	This Agreement shall bind and inure to the benefit of the Parties and their permitted successors and assigns.

		
	13.2
	The captions and headings contained in this Agreement are used for convenience only and shall not be deemed or construed to have any substantive content in interpreting the meaning of any of the provisions of this Agreement.

		
	13.3
	The Parties to this Agreement are independent contractors.  This Agreement does not create a relationship of agency, partnership, joint venture, employment or franchise between the Parties.  This Agreement does not give either Party the authority to bind the other or to incur any obligation on the other’s behalf.

		
	14.
	COUNTERPARTS.  The Parties agree that this Agreement may be signed in multiple, identical counterparts.

IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the day and year first above written.

	
		
	THE SCOTTS COMPANY LLC

By:_/s/ JAMES HAGEDORN___________

Title: President and Chief Executive Officer

	MONSANTO COMPANY

By: _/s/ HUGH GRANT_______________

Title: Chairman and Chief Executive Officer

Page 10 of 10EX-4.1

 Exhibit 4.1 

BLACK KNIGHT FINANCIAL SERVICES, INC. 

2015 OMNIBUS INCENTIVE PLAN 

(as of April 30, 2015) 

 TABLE OF CONTENTS 

 

									
	 		 		 		Page	 
			
	 Article 1.
		 Establishment, Objectives, and Duration
		 	1	  
				
			 1.1.
		 Establishment of the Plan
		 	1	  
			 1.2.
		 Objectives of the Plan
		 	1	  
			1.3.		 Duration of the Plan
		 	1	  
			
	 Article 2.
		 Definitions
		 	1	  
			
	 Article 3.
		 Administration
		 	5	  
				
			 3.1.
		 The Committee
		 	5	  
			 3.2.
		 Authority of the Committee
		 	5	  
			 3.3.
		 Decisions Binding
		 	5	  
			
	 Article 4.
		 Shares Subject to the Plan; Individual Limits; and Anti-Dilution Adjustments
		 	6	  
				
			 4.1.
		 Number of Shares Available for Grants
		 	6	  
			4.2.		 Individual Limits
		 	7	  
			 4.3.
		 Adjustments in Authorized Shares and Awards
		 	7	  
			
	 Article 5.
		 Eligibility and Participation
		 	8	  
				
			 5.1.
		 Eligibility
		 	8	  
			 5.2.
		 Actual Participation
		 	8	  
			
	 Article 6.
		 Options
		 	8	  
				
			 6.1.
		 Grant of Options
		 	8	  
			 6.2.
		 Award Agreement
		 	8	  
			 6.3.
		 Exercise Price
		 	8	  
			 6.4.
		 Duration of Options
		 	8	  
			 6.5.
		 Exercise of Options
		 	9	  
			 6.6.
		 Payment
		 	9	  
			 6.7.
		 Restrictions on Share Transferability
		 	9	  
			 6.8.
		 Dividend Equivalents
		 	9	  
			 6.9.
		 Termination of Employment or Service
		 	9	  
			 6.10.
		 Nontransferability of Options
		 	9	  
			
	 Article 7.
		 Stock Appreciation Rights
		 	10	  
				
			 7.1.
		 Grant of SARs
		 	10	  
			 7.2.
		 Exercise of Tandem SARs
		 	10	  
			 7.3.
		 Exercise of Freestanding SARs
		 	10	  
			 7.4.
		 Award Agreement
		 	11	  
			 7.5.
		 Term of SARs
		 	11	  
			 7.6.
		 Payment of SAR Amount
		 	11	  
			 7.7.
		 Dividend Equivalents
		 	11	  
			 7.8.
		 Termination of Employment or Service
		 	11	  
			 7.9.
		 Nontransferability of SARs
		 	11	  

  
 -i- 

 TABLE OF CONTENTS 

(continued) 
  

									
	 		 		 		Page	 
			
	 Article 8.
		 Restricted Stock
		 	11	  
				
			8.1.		 Grant of Restricted Stock
		 	11	  
			 8.2.
		 Award Agreement
		 	12	  
			 8.3.
		 Other Restrictions
		 	12	  
			 8.4.
		 Removal of Restrictions
		 	12	  
			 8.5.
		 Voting Rights
		 	12	  
			 8.6.
		 Dividends and Other Distributions
		 	12	  
			 8.7.
		 Termination of Employment or Service
		 	12	  
			 8.8.
		 Nontransferability of Restricted Stock
		 	13	  
			
	 Article 9.
		 Restricted Stock Units and Performance Shares
		 	13	  
				
			 9.1.
		 Grant of Restricted Stock Units/Performance Shares
		 	13	  
			 9.2.
		 Award Agreement
		 	13	  
			 9.3.
		 Form and Timing of Payment
		 	13	  
			 9.4.
		 Voting Rights
		 	13	  
			 9.5.
		 Dividend Equivalents
		 	13	  
			 9.6.
		 Termination of Employment or Service
		 	14	  
			 9.7.
		 Nontransferability
		 	14	  
			
	 Article 10.
		 Performance Units
		 	14	  
				
			 10.1.
		 Grant of Performance Units
		 	14	  
			 10.2.
		 Award Agreement
		 	14	  
			 10.3.
		 Value of Performance Units
		 	14	  
			 10.4.
		 Form and Timing of Payment
		 	14	  
			 10.5.
		 Dividend Equivalents
		 	14	  
			 10.6.
		 Termination of Employment or Service
		 	15	  
			 10.7.
		 Nontransferability
		 	15	  
			
	 Article 11.
		 Other Awards
		 	15	  
				
			 11.1.
		 Grant of Other Awards
		 	15	  
			 11.2.
		 Payment of Other Awards
		 	15	  
			 11.3.
		 Termination of Employment or Service
		 	15	  
			 11.4.
		 Nontransferability
		 	15	  
			 11.5.
		 LLC Conversion Awards
		 	15	  
			
	 Article 12.
		 Replacement Awards
		 	16	  
			
	 Article 13.
		 Performance Measures
		 	16	  
			
	 Article 14.
		 Beneficiary Designation
		 	17	  
			
	 Article 15.
		 Deferrals
		 	17	  
			
	 Article 16.
		 Rights of Participants
		 	17	  
				
			 16.1.
		 Continued Service
		 	17	  
			 16.2.
		 Participation
		 	17	  

  
 -ii- 

 TABLE OF CONTENTS 

(continued) 
  

									
	 		 		 		Page	 
			
	 Article 17.
		 Change in Control
		 	18	  
			
	 Article 18.
		 Additional Forfeiture Provisions
		 	18	  
			
	 Article 19.
		 Amendment, Modification, Termination, and Stockholder Approval
		 	18	  
				
			 19.1.
		 Amendment, Modification, and Termination
		 	18	  
			 19.2.
		 Adjustment of Awards Upon the Occurrence of Certain Unusual or Nonrecurring Events
		 	19	  
			 19.3.
		 Awards Previously Granted
		 	19	  
			 19.4.
		 Compliance with the Performance-Based Exception
		 	19	  
			 19.5.
		 Stockholder Approval
		 	19	  
			
	 Article 20.
		 Withholding
		 	19	  
				
			 20.1.
		 Tax Withholding
		 	19	  
			 20.2.
		 Use of Shares to Satisfy Withholding Obligation
		 	20	  
			
	 Article 21.
		 Indemnification
		 	20	  
			
	 Article 22.
		 Successors
		 	20	  
			
	 Article 23.
		 Limitation on Dividends and Dividend Equivalents
		 	21	  
			
	 Article 24.
		 Minimum Vesting Period
		 	21	  
			
	 Article 25.
		 Legal Construction
		 	21	  
				
			25.1.		 Gender, Number and References
		 	21	  
			 25.2.
		 Severability
		 	21	  
			 25.3.
		 Requirements of Law
		 	21	  
			 25.4.
		 Governing Law
		 	21	  
			 25.5.
		 Non-Exclusive Plan
		 	21	  
			 25.6.
		 Code Section 409A Compliance
		 	22	  

  
 -iii- 

 Black Knight Financial Services, Inc. 

2015 Omnibus Incentive Plan 

(as of April 30, 2015) 
 Article 1.
Establishment, Objectives, and Duration 
 1.1. Establishment of the Plan. Black Knight Financial Services, Inc., a
Delaware corporation (hereinafter referred to as the “Company”), hereby establishes an incentive compensation plan to be known as the “Black Knight Financial Services, Inc. 2015 Omnibus Incentive Plan” (hereinafter referred to as
the “Plan”), effective as of April 30, 2015 (the “Effective Date”). The Plan permits the granting of Nonqualified Stock Options, Incentive Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units,
Performance Shares, Performance Units, Replacement Awards and Other Awards. 
 1.2. Objectives of the Plan. The objectives of
the Plan are to optimize the profitability and growth of the Company through incentives that are consistent with the Company’s goals and that link the personal interests of Participants to those of the Company’s stockholders. 

The Plan is further intended to provide flexibility to the Company in its ability to motivate, attract and retain the services of Participants
who make or are expected to make significant contributions to the Company’s success and to allow Participants to share in the success of the Company. 

1.3. Duration of the Plan. No Award may be granted under the Plan after the day immediately preceding the tenth anniversary of
the Effective Date, or such earlier date as the Board shall determine. The Plan will remain in effect with respect to outstanding Awards until no Awards remain outstanding. 

Article 2. Definitions 
 The following
terms, when capitalized, shall have the meanings set forth below: 
 2.1. “Award” means, individually or
collectively, Nonqualified Stock Options, Incentive Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Shares, Performance Units, and Other Awards granted under the Plan. 

2.2. “Award Agreement” means an agreement entered into by the Company and a Participant setting forth the terms and
provisions applicable to an Award. 
 2.3. “Beneficial Ownership” shall have the meaning ascribed to such term in
Rule 13d-3 of the General Rules and Regulations under the Exchange Act. 
 2.4. “Board” means the Board of Directors
of the Company. 

 2.5. “Change in Control” means that the conditions set forth in any one
of the following subsections shall have been satisfied: 
 (a) an acquisition immediately after which any Person, other than Fidelity
National Financial, Inc. (“Fidelity”), possesses direct or indirect Beneficial Ownership of 25% or more of either the then outstanding shares of Company common stock (the “Outstanding Company Common Stock”) or the combined voting
power of the then outstanding voting securities of the Company entitled to vote generally in the election of directors (the “Outstanding Company Voting Securities”); provided that the following acquisitions shall be excluded: (i) any
acquisition directly from the Company, other than an acquisition by virtue of the exercise of a conversion privilege unless the security being so converted was itself acquired directly from the Company, (ii) any acquisition by the Company,
(iii) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or a Subsidiary, or (iv) any acquisition pursuant to a transaction that complies with paragraphs (i), (ii) and (iii) of
subsection (c) of this Section 2.5; or 
 (b) during any period of two consecutive years, the individuals who, as of the beginning
of such period, constitute the Board (such Board shall be hereinafter referred to as the “Incumbent Board”) cease for any reason to constitute at least a majority of the Board; provided that for purposes of this Section 2.5, any
individual who becomes a member of the Board subsequent to the beginning of such period and whose election, or nomination for election by the Company’s shareholders, was approved by a vote of at least two-thirds of those individuals who are
members of the Board and who were also members of the Incumbent Board (or deemed to be such pursuant to this proviso) shall be considered as though such individual were a member of the Incumbent Board; provided, further, that any such individual
whose initial assumption of office occurs as a result of either an actual or threatened election contest or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board shall not be so considered as
a member of the Incumbent Board; or 
 (c) consummation of a reorganization, merger, share exchange, consolidation or sale or other
disposition of all or substantially all of the assets of the Company (“Corporate Transaction”); excluding, however, such a Corporate Transaction pursuant to which: 

(i) all or substantially all of the individuals and entities who have Beneficial Ownership, respectively, of the Outstanding
Company Common Stock and Outstanding Company Voting Securities immediately prior to such Corporate Transaction will have Beneficial Ownership, directly or indirectly, of more than 50% of, respectively, the outstanding shares of common stock and the
combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors, as the case may be, of the corporation resulting from such Corporate Transaction (including, without limitation, the Company or
a corporation that as a result of such transaction owns the Company or all or substantially all of the Company’s assets either directly or through one or more subsidiaries) (the “Resulting Corporation”) in substantially the same
proportions 

  
 2 

 
as their ownership, immediately prior to such Corporate Transaction, of the Outstanding Company Common Stock and Outstanding Company Voting Securities, as the case may be; 

(ii) no Person (other than (1) the Company, (2) Fidelity, (3) an employee benefit plan (or related trust)
sponsored or maintained by the Company, Resulting Corporation, or Fidelity, or (4) any entity controlled by the Company, Resulting Corporation, or Fidelity) will have Beneficial Ownership, directly or indirectly, of 25% or more of,
respectively, the outstanding shares of common stock of the Resulting Corporation or the combined voting power of the outstanding voting securities of the Resulting Corporation entitled to vote generally in the election of directors, except to the
extent that such ownership existed prior to the Corporate Transaction; and 
 (iii) individuals who were members of the
Incumbent Board will continue to constitute at least a majority of the members of the board of directors of the Resulting Corporation; or 

(d) the approval by the stockholders of the Company of a complete liquidation or dissolution of the Company. 

2.6. “Code” means the Internal Revenue Code of 1986, as amended from time to time. 

2.7. “Committee” means the entity, as specified in Section 3.1, authorized to administer the Plan. 

2.8. “Company” means Black Knight Financial Services, Inc., a Delaware corporation, and any successor thereto. 

2.9. “Consultant” means any consultant or advisor to the Company or a Subsidiary. 

2.10. “Director” means any individual who is a member of the Board of Directors of the Company or a Subsidiary. 

2.11. “Dividend Equivalent” means, with respect to Shares subject to an Award, a right to be paid an amount equal to
the dividends declared and paid on an equal number of outstanding Shares of the same class. 
 2.12. “Employee”
means any employee of the Company or a Subsidiary. 
 2.13. “Exchange Act” means the Securities Exchange Act of
1934, as amended from time to time. 
 2.14. “Exercise Price” means the price at which a Share may be purchased by a
Participant pursuant to an Option. 

  
 3 

 2.15. “Fair Market Value” means the fair market value of a Share as
determined in good faith by the Committee or pursuant to a procedure specified in good faith by the Committee; provided, however, that if the Committee has not specified otherwise, Fair Market Value shall mean the closing price of a Share as
reported in a consolidated transaction reporting system on the date of valuation, or, if there was no such sale on the relevant date, then on the last previous day on which a sale was reported. 

2.16. “Freestanding SAR” means an SAR that is granted independently of any Options, as described in Article 7 herein.

 2.17. “Incentive Stock Option” or “ISO” means an Option that is intended to meet the requirements of
Code Section 422. 
 2.18. “Nonqualified Stock Option” or “NQSO” means an Option that is not intended
to meet the requirements of Code Section 422. 
 2.19. “Option” means an Incentive Stock Option or a
Nonqualified Stock Option granted under the Plan, as described in Article 6 herein. 
 2.20. “Other Award”
means a cash, Share-based or Share-related Award (other than an Award described in Article 6, 7, 8, 9 or 10 of the Plan) that is granted pursuant to Article 11 herein. 

2.21. “Participant” means a current or former Employee, Director or Consultant who has rights relating to an outstanding
Award. 
 2.22. “Performance-Based Exception” means the performance-based exception from the tax deductibility
limitations of Code Section 162(m). 
 2.23. “Performance Period” means the period during which a performance
measure must be met. 
 2.24. “Performance Share” means an Award granted to a Participant, as described in Article 9
herein. 
 2.25. “Performance Unit” means an Award granted to a Participant, as described in Article 10 herein. 

2.26. “Period of Restriction” means the period Restricted Stock or Restricted Stock Units are subject to a substantial
risk of forfeiture and are not transferable, as provided in Articles 8 and 9 herein. 
 2.27. “Person” shall have
the meaning ascribed to such term in Section 3(a)(9) of the Exchange Act and used in Sections 13(d) and 14(d) thereof. 
 2.28.
“Replacement Awards” means Awards issued in assumption of or substitution for awards granted under equity-based incentive plans sponsored or maintained by an entity with which the Company engages in a merger, acquisition or

  
 4 

 
other business transaction, pursuant to which awards relating to interests in such entity (or a related entity) are outstanding immediately prior to such merger, acquisition or other business
transaction. Except as provided in Section 4.1, for all purposes hereunder, Replacement Awards shall be deemed Awards. 
 2.29.
“Restricted Stock” means an Award granted to a Participant, as described in Article 8 herein. 
 2.30.
“Restricted Stock Unit” means an Award granted to a Participant, as described in Article 9 herein. 
 2.31.
“Share” means a share of Class A common stock of the Company, having a par value of $0.0001 per share, subject to adjustment pursuant to Section 4.3 hereof. 

2.32. “Stock Appreciation Right” or “SAR” means an Award granted to a Participant, either
alone or in connection with a related Option, as described in Article 7 herein. 
 2.33. “Subsidiary” means
(i) any corporation in which the Company owns, directly or indirectly, at least fifty percent (50%) of the total combined voting power of all classes of stock, or any other entity (including, but not limited to, partnerships and joint
ventures) in which the Company owns, directly or indirectly, at least fifty percent (50%) of the combined equity thereof, and (ii) any other affiliate of the Company that has been designated by the Committee for purposes of the
participation of its employees in the Plan. Notwithstanding the foregoing, for purposes of determining whether any individual may be a Participant for purposes of any grant of Incentive Stock Options, “Subsidiary” shall have the meaning
ascribed to such term in Code Section 424(f). 
 2.34. “Tandem SAR” means an SAR that is granted in connection
with a related Option, as described in Article 7 herein. 
 Article 3. Administration 

3.1. The Committee. The Plan shall be administered by the Compensation Committee of the Board or such other committee as the
Board shall select (the “Committee”). The members of the Committee shall be appointed from time to time by, and shall serve at the discretion of, the Board. 

3.2. Authority of the Committee. Except as limited by law or by the Certificate of Incorporation or Bylaws of the Company, and
subject to the provisions herein, the Committee shall have full power to select the Employees, Directors and Consultants who shall participate in the Plan; determine the sizes and types of Awards; determine the terms and conditions of Awards in a
manner consistent with the Plan; construe and interpret the Plan and any Award Agreement or other agreement or instrument entered into in connection with the Plan; establish, amend, or waive rules and regulations for the Plan’s administration;
and, subject to the provisions of Section 19.3 herein, amend the terms and conditions of any outstanding Award and Award Agreement. Further, the Committee shall make all other determinations that may be necessary or advisable for the
administration of the Plan. As permitted by law, the Committee may delegate its authority as identified herein. 
 3.3. Decisions
Binding. All determinations and decisions made by the Committee pursuant to the provisions of the Plan and all related orders and resolutions of the Board shall be final, conclusive and binding on all persons, including the Company, its
Subsidiaries, its stockholders, Directors, Employees, Consultants and their estates and beneficiaries and any transferee of an Award. 

  
 5 

 Article 4. Shares Subject to the Plan; Individual Limits; and Anti-Dilution Adjustments 

4.1. Number of Shares Available for Grants. 

(a) Subject to adjustment as provided in Section 4.3 herein, the maximum number of Shares that may be delivered pursuant to Awards under
the Plan shall be 10,994,215, provided that: 
 (i) Shares that are potentially deliverable under an Award that is canceled,
forfeited, settled in cash, expires or is otherwise terminated without delivery of such Shares shall not be counted as having been delivered under the Plan; 

(ii) Shares that are held back, tendered or returned to cover the Exercise Price or tax withholding obligations with respect to
an Award shall not be counted as having been delivered under the Plan; and 
 (iii) Shares that have been issued in
connection with an Award of Restricted Stock that is canceled or forfeited prior to vesting or settled in cash, causing the Shares to be returned to the Company, shall not be counted as having been delivered under the Plan. 

Shares delivered pursuant to the Plan may be authorized but unissued Shares, treasury Shares or Shares purchased on the open market. Shares
delivered or deliverable pursuant to Replacement Awards shall not reduce the number of Shares available for delivery pursuant to Awards under the Plan. 

(b) Subject to adjustment as provided in Section 4.3 herein, all Shares authorized under the Plan and available for grant may be
delivered in connection with “full value Awards,” meaning Awards other than Options, SARs, or Other Awards for which the Participant pays the grant date intrinsic value. 

(c) Notwithstanding the foregoing, for purposes of determining the number of Shares available for grant as Incentive Stock Options, only
Shares that are subject to an Award that expires or is cancelled, forfeited or settled in cash shall be treated as not having been issued under the Plan. 

  
 6 

 4.2. Individual Limits. Subject to adjustment as provided in
Section 4.3 herein, the following rules shall apply with respect to Awards and any related dividends or Dividend Equivalents intended to qualify for the Performance-Based Exception: 

(a) Options: The maximum aggregate number of Shares with respect to which Options may be granted in any one fiscal year to any one
Participant shall be 4,000,000 Shares. 
 (b) SARs: The maximum aggregate number of Shares with respect to which Stock Appreciation
Rights may be granted in any one fiscal year to any one Participant shall be 4,000,000 Shares. 
 (c) Restricted Stock: The maximum
aggregate number of Shares of Restricted Stock that may be granted in any one fiscal year to any one Participant shall be 2,000,000 Shares. 

(d) Restricted Stock Units: The maximum aggregate number of Shares with respect to which Restricted Stock Units may be granted in any
one fiscal year to any one Participant shall be 2,000,000 Shares. 
 (e) Performance Shares: The maximum aggregate number of Shares
with respect to which Performance Shares may be granted in any one fiscal year to any one Participant shall be 2,000,000 Shares. 
 (f)
Performance Units: The maximum aggregate compensation that can be paid pursuant to Performance Units awarded in any one fiscal year to any one Participant shall be $25,000,000 or a number of Shares having an aggregate Fair Market Value not in
excess of such amount. 
 (g) Other Awards: The maximum aggregate compensation that can be paid pursuant to Other Awards (other than
LLC Conversion Awards) awarded in any one fiscal year to any one Participant shall be $25,000,000 or a number of Shares having an aggregate Fair Market Value not in excess of such amount. 

(h) Dividends and Dividend Equivalents: The maximum dividend or Dividend Equivalent that may be paid in any one fiscal year to any one
Participant shall be $25,000,000. 
 4.3. Adjustments in Authorized Shares and Awards. In the event of any merger,
reorganization, consolidation, recapitalization, liquidation, stock dividend, split-up, spin-off, stock split, reverse stock split, share combination, share exchange, extraordinary dividend, or any change in the corporate structure affecting the
Shares, such adjustment shall be made in the number and kind of shares that may be delivered under the Plan as set forth in Section 4.1(a) and (b), the individual limits set forth in Section 4.2, and, with respect to outstanding Awards,
the number and kind of shares subject to outstanding Awards, the Exercise Price, grant price or other price of shares subject to outstanding Awards, any performance conditions relating to shares, the market price of shares, or per-share results, and
other terms and conditions of outstanding 

  
 7 

 
Awards, as may be determined to be appropriate and equitable by the Committee, in its sole discretion, to prevent dilution or enlargement of rights; provided, however, that, unless otherwise
determined by the Committee, the number of shares subject to any Award shall always be rounded down to a whole number. 
 Article 5. Eligibility and
Participation 
 5.1. Eligibility. Persons eligible to participate in the Plan include all Employees, Directors and
Consultants. 
 5.2. Actual Participation. Subject to the provisions of the Plan, the Committee may, from time to time, select
from all eligible Employees, Directors and Consultants, those to whom Awards shall be granted and shall determine the nature and amount of each Award. 

Article 6. Options 
 6.1. Grant of
Options. Subject to the terms and provisions of the Plan, Options may be granted to Participants in such amounts, upon such terms, and at such times as the Committee shall determine. 

6.2. Award Agreement. Each Option grant shall be evidenced by an Award Agreement that shall specify the Exercise Price, the
duration of the Option, the number of Shares to which the Option pertains, and such other provisions as the Committee shall determine. The Award Agreement also shall specify whether the Option is intended to be an ISO or an NQSO. Options that are
intended to be ISOs shall be subject to the limitations set forth in Code Section 422. 
 6.3. Exercise Price. The
Exercise Price for each grant of an Option under the Plan shall be at least equal to one hundred percent (100%) of the Fair Market Value of a Share (of the same class as the Shares that are subject to the Option) on the date the Option is
granted; provided, however, that this restriction shall not apply to Replacement Awards or Awards that are adjusted pursuant to Section 4.3 herein. No ISO granted to a Participant who, at the time the ISO is granted, owns stock representing
more than ten percent (10%) of the voting power of all classes of stock of the Company or any Subsidiary shall have an Exercise Price that is less than one hundred ten percent (110%) of the Fair Market Value of a Share (of the same class
as the Shares that are subject to the ISO) on the date the ISO is granted. 
 6.4. Duration of Options. Each Option granted to
a Participant shall expire at such time as the Committee shall determine at the time of grant; provided, however, that no Option shall be exercisable later than the tenth (10th) anniversary date of its grant. No ISO granted to a Participant
who, at the time the ISO is granted, owns stock representing more than ten percent (10%) of the voting power of all classes of stock of the Company or any Subsidiary shall be exercisable later than the fifth (5th) anniversary of the date
of its grant. 

  
 8 

 6.5. Exercise of Options. Options granted under this Article 6 shall be exercisable
at such times and be subject to such restrictions and conditions as set forth in the Award Agreement and as the Committee shall in each instance approve, which need not be the same for each grant or for each Participant. 

6.6. Payment. Options granted under this Article 6 shall be exercised by the delivery of a written notice of exercise to the
Company, setting forth the number of Shares with respect to which the Option is to be exercised and specifying the method of payment of the Exercise Price. 

The Exercise Price of an Option shall be payable to the Company in full: (a) in cash or its equivalent, (b) by tendering Shares or
directing the Company to withhold Shares from the Option having an aggregate Fair Market Value at the time of exercise equal to the Exercise Price, (c) by broker-assisted cashless exercise, (d) in any other manner then permitted by the
Committee, or (e) by a combination of any of the permitted methods of payment. The Committee may limit any method of payment, other than that specified under (a), for administrative convenience, to comply with applicable law, or for any other
reason. 
 6.7. Restrictions on Share Transferability. The Committee may impose such restrictions on any Shares acquired
pursuant to the exercise of an Option granted under this Article 6 as it may deem advisable, including, without limitation, restrictions under applicable federal securities laws, under the requirements of any stock exchange or market upon which such
Shares are then listed and/or traded, and under any blue sky or state securities laws applicable to such Shares. 
 6.8. Dividend
Equivalents. At the discretion of the Committee, an Award of Options may provide the Participant with the right to receive Dividend Equivalents, which will be credited to an account for the Participant and subject to the restrictions and
vesting conditions applicable to such Award, and may be settled in cash and/or Shares, as determined by the Committee in its sole discretion, subject in each case to such terms and conditions as the Committee shall establish. Notwithstanding
anything herein to the contrary, in no event shall Dividend Equivalents be currently payable with respect to unearned Awards. 
 6.9.
Termination of Employment or Service. Each Participant’s Option Award Agreement shall set forth the extent to which the Participant shall have the right to exercise the Option following termination of the Participant’s
employment or, if the Participant is a Director or Consultant, service with the Company and/or a Subsidiary, as the case may be. Such provisions shall be determined in the sole discretion of the Committee, need not be uniform among all Options, and
may reflect distinctions based on the reasons for termination of employment or service. 
 6.10. Nontransferability of
Options. 
 (a) Incentive Stock Options. ISOs may not be sold, transferred, pledged, assigned, or otherwise alienated or
hypothecated, other than by will or by the laws of descent and distribution, and shall be exercisable during a Participant’s lifetime only by such Participant. 

(b) Nonqualified Stock Options. NQSOs may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other
than by will or by the laws of descent and distribution, and shall be exercisable during a Participant’s lifetime only by such Participant. 

  
 9 

 Article 7. Stock Appreciation Rights 

7.1. Grant of SARs. Subject to the terms and provisions of the Plan, SARs may be granted to Participants in such amounts, upon such
terms, and at such times as the Committee shall determine. The Committee may grant Freestanding SARs, Tandem SARs, or any combination of these forms of SAR. 

The Committee shall have complete discretion in determining the number of SARs granted to each Participant (subject to Article 4 herein) and,
consistent with the provisions of the Plan, in determining the terms and conditions pertaining to such SARs. 
 The grant price of a
Freestanding SAR shall at least equal the Fair Market Value of a Share (of the same class as the Shares that are subject to the SAR) on the date of grant of the SAR, and the grant price of a Tandem SAR shall equal the Exercise Price of the related
Option; provided, however, that this restriction shall not apply to Replacement Awards or Awards that are adjusted pursuant to Section 4.3 herein. 

7.2. Exercise of Tandem SARs. A Tandem SAR may be exercised only with respect to the Shares for which its related Option is then
exercisable. To the extent exercisable, Tandem SARs may be exercised for all or part of the Shares subject to the related Option. The exercise of all or part of a Tandem SAR shall result in the forfeiture of the right to purchase a number of Shares
under the related Option equal to the number of Shares with respect to which the SAR is exercised. Conversely, upon exercise of all or part of an Option with respect to which a Tandem SAR has been granted, an equivalent portion of the Tandem SAR
shall similarly be forfeited. 
 Notwithstanding any other provision of the Plan to the contrary, with respect to a Tandem SAR granted in
connection with an ISO: (i) the Tandem SAR will expire no later than the expiration of the underlying ISO; (ii) the value of the payout with respect to the Tandem SAR may be for no more than one hundred percent (100%) of the
difference between the Exercise Price of the underlying ISO and the Fair Market Value of the Shares subject to the underlying ISO at the time the Tandem SAR is exercised; and (iii) the Tandem SAR may be exercised only when the Fair Market Value
of the Shares subject to the ISO exceeds the Exercise Price of the ISO. 
 7.3. Exercise of Freestanding SARs. Freestanding
SARs may be exercised upon whatever terms and conditions the Committee, in its sole discretion, imposes upon them and sets forth in the Award Agreement. 

  
 10 

 7.4. Award Agreement. Each SAR grant shall be evidenced by an Award Agreement that
shall specify the grant price, the term of the SAR, and such other provisions as the Committee shall determine. 
 7.5. Term of
SARs. The term of an SAR granted under the Plan shall be determined by the Committee, in its sole discretion; provided, however, that such term shall not exceed ten (10) years. 

7.6. Payment of SAR Amount. Upon exercise of an SAR, a Participant shall be entitled to receive payment from the Company in an
amount determined by multiplying: 
 (a) the difference between the Fair Market Value of a Share (of the same class as the Shares that are
subject to the SAR) on the date of exercise over the grant price; by 
 (b) the number of Shares with respect to which the SAR is exercised.

 At the discretion of the Committee, the payment upon SAR exercise may be in cash, in Shares of equivalent value, or in some combination
thereof. 
 7.7. Dividend Equivalents. At the discretion of the Committee, an Award of SARs may provide the Participant with
the right to receive Dividend Equivalents, which will be credited to an account for the Participant and subject to the restrictions and vesting conditions applicable to such Award, and may be settled in cash and/or Shares, as determined by the
Committee in its sole discretion, subject in each case to such terms and conditions as the Committee shall establish. Notwithstanding anything herein to the contrary, in no event shall Dividend Equivalents be currently payable with respect to
unearned Awards. 
 7.8. Termination of Employment or Service. Each SAR Award Agreement shall set forth the extent to which
the Participant shall have the right to exercise the SAR following termination of the Participant’s employment or, if the Participant is a Director or Consultant, service with the Company and/or a Subsidiary, as the case may be. Such provisions
shall be determined in the sole discretion of the Committee, need not be uniform among all SARs, and may reflect distinctions based on the reasons for termination of employment or service. 

7.9. Nontransferability of SARs. SARs may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated,
other than by will or by the laws of descent and distribution, and shall be exercisable during a Participant’s lifetime only by such Participant. 

Article 8. Restricted Stock 
 8.1.
Grant of Restricted Stock. Subject to the terms and provisions of the Plan, Restricted Stock may be granted to Participants in such amounts, upon such terms, and at such times as the Committee shall determine. 

  
 11 

 8.2. Award Agreement. Each Restricted Stock grant shall be evidenced by an Award
Agreement that shall specify the Period(s) of Restriction and, if applicable, Performance Period(s), the number of Shares of Restricted Stock granted, and such other provisions as the Committee shall determine. 

8.3. Other Restrictions. The Committee shall impose such other conditions and/or restrictions on any Shares of Restricted Stock
granted pursuant to the Plan as it may deem advisable including, without limitation, a requirement that Participants pay a stipulated purchase price for each Share of Restricted Stock, a requirement that the issuance of Shares of Restricted Stock be
delayed, restrictions based upon the achievement of specific performance goals, time-based restrictions on vesting following the attainment of the performance goals, time-based restrictions, and/or restrictions under applicable laws or under the
requirements of any stock exchange or market upon which such Shares are listed or traded, or holding requirements or sale restrictions placed on the Shares by the Company upon vesting of such Restricted Stock. The Company may retain in its custody
any certificate evidencing the Shares of Restricted Stock and place thereon a legend and institute stop-transfer orders on such Shares, and the Participant shall be obligated to sign any stock power requested by the Company relating to the Shares to
give effect to the forfeiture provisions of the Restricted Stock. 
 8.4. Removal of Restrictions. Subject to applicable laws,
Restricted Stock shall become freely transferable by the Participant after the last day of the Period of Restriction applicable thereto. Once Restricted Stock is released from the restrictions, the Participant shall be entitled to receive a
certificate evidencing the Shares. 
 8.5. Voting Rights. Unless otherwise determined by the Committee and set forth in a
Participant’s Award Agreement, to the extent permitted or required by law, as determined by the Committee, Participants holding Shares of Restricted Stock granted hereunder may exercise full voting rights with respect to those Shares during the
Period of Restriction. 
 8.6. Dividends and Other Distributions. Except as otherwise provided in a Participant’s Award
Agreement, during the Period of Restriction, all distributions, including regular cash dividends, paid with respect to Shares of Restricted Stock shall be credited to Participants subject to the same restrictions on transferability and
forfeitability as the Restricted Stock with respect to which they were paid and paid at such time following full vesting as are paid the Shares of Restricted Stock with respect to which such distributions were made. 

8.7. Termination of Employment or Service. Each Award Agreement shall set forth the extent to which the Participant shall have
the right to retain unvested Restricted Stock following termination of the Participant’s employment or, if the Participant is a Director or Consultant, service with the Company and/or a Subsidiary, as the case may be. Such provisions shall be
determined in the sole discretion of the Committee, need not be uniform among all Awards of Restricted Stock, and may reflect distinctions based on the reasons for termination of employment or service. 

  
 12 

 8.8. Nontransferability of Restricted Stock. Except as otherwise determined by the
Committee, during the applicable Period of Restriction, a Participant’s Restricted Stock and rights relating thereto shall be available during the Participant’s lifetime only to such Participant, and such Restricted Stock and related
rights may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated other than by will or by the laws of descent and distribution. 

Article 9. Restricted Stock Units and Performance Shares 

9.1. Grant of Restricted Stock Units/Performance Shares. Subject to the terms and provisions of the Plan, Restricted Stock Units
and Performance Shares may be granted to Participants in such amounts, upon such terms, and at such times as the Committee shall determine. 

9.2. Award Agreement. Each grant of Restricted Stock Units or Performance Shares shall be evidenced by an Award Agreement that
shall specify the applicable Period(s) of Restriction and/or Performance Period(s) (as the case may be), the number of Restricted Stock Units or Performance Shares granted, and such other provisions as the Committee shall determine. The initial
value of a Restricted Stock Unit or Performance Share shall be at least equal to the Fair Market Value of a Share (of the same class as the Shares that are subject to the Award) on the date of grant; provided, however, that this restriction shall
not apply to Replacement Awards or Awards that are adjusted pursuant to Section 4.3 herein. 
 9.3. Form and Timing of
Payment. Except as otherwise provided in Article 17 herein or a Participant’s Award Agreement, payment of Restricted Stock Units or Performance Shares shall be made at a specified settlement date that shall not be earlier than the last
day of the Period of Restriction or Performance Period, as the case may be. The Committee, in its sole discretion, may pay earned Restricted Stock Units and Performance Shares by delivery of Shares or by payment in cash of an amount equal to the
Fair Market Value of such Shares (or a combination thereof). The Committee may provide that settlement of Restricted Stock Units or Performance Shares shall be deferred, on a mandatory basis or at the election of the Participant. 

9.4. Voting Rights. A Participant shall have no voting rights with respect to any Restricted Stock Units or Performance Shares
granted hereunder; provided, however, that the Committee may deposit Shares potentially deliverable in connection with Restricted Stock Units or Performance Shares in a rabbi trust, in which case the Committee may provide for pass through voting
rights with respect to such deposited Shares. 
 9.5. Dividend Equivalents. At the discretion of the Committee, an Award of
Restricted Stock Units or Performance Shares may provide the Participant with the right to receive Dividend Equivalents, which will be credited to an account for the Participant and subject to the restrictions and vesting conditions applicable to
such Award, and may be settled in cash and/or Shares, as determined by the Committee in its sole discretion, subject in each case to such terms and conditions as the Committee shall establish. Notwithstanding anything herein to the contrary, in no
event shall Dividend Equivalents be currently payable with respect to unearned Awards. 

  
 13 

 9.6. Termination of Employment or Service. Each Award Agreement shall set forth the
extent to which the Participant shall have the right to receive a payout with respect to an Award of Restricted Stock Units or Performance Shares following termination of the Participant’s employment or, if the Participant is a Director or
Consultant, service with the Company and/or a Subsidiary, as the case may be. Such provisions shall be determined in the sole discretion of the Committee, need not be uniform among all Restricted Stock Units or Performance Shares, and may reflect
distinctions based on the reasons for termination of employment or service. 
 9.7. Nontransferability. Except as otherwise
determined by the Committee, Restricted Stock Units and Performance Shares and rights relating thereto may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent and
distribution. 
 Article 10. Performance Units 

10.1. Grant of Performance Units. Subject to the terms and conditions of the Plan, Performance Units may be granted to
Participants in such amounts, upon such terms, and at such times as the Committee shall determine. 
 10.2. Award Agreement.
Each grant of Performance Units shall be evidenced by an Award Agreement that shall specify the number of Performance Units granted, the Performance Period(s), the performance goals and such other provisions as the Committee shall determine. 

10.3. Value of Performance Units. The Committee shall set performance goals in its discretion that, depending on the extent to
which they are met, will determine the number and/or value of Performance Units that will be paid out to the Participants. 
 10.4.
Form and Timing of Payment. Except as otherwise provided in Article 17 herein or a Participant’s Award Agreement, payment of earned Performance Units shall be made following the close of the applicable Performance Period. The
Committee, in its sole discretion, may pay earned Performance Units in cash or in Shares that have an aggregate Fair Market Value equal to the value of the earned Performance Units (or a combination thereof). The Committee may provide that
settlement of Performance Units shall be deferred, on a mandatory basis or at the election of the Participant. 
 10.5. Dividend
Equivalents. At the discretion of the Committee, an Award of Performance Units may provide the Participant with the right to receive Dividend Equivalents, which will be credited to an account for the Participant and subject to the
restrictions and vesting conditions applicable to such Award, and may be settled in cash and/or Shares, as determined by the Committee in its sole discretion, subject in each case to such terms and conditions as the Committee shall establish.
Notwithstanding anything herein to the contrary, in no event shall Dividend Equivalents be currently payable with respect to unearned Awards. 

  
 14 

 10.6. Termination of Employment or Service. Each Award Agreement shall set forth
the extent to which the Participant shall have the right to receive a payout with respect to an Award of Performance Units following termination of the Participant’s employment or, if the Participant is a Director or Consultant, service with
the Company and/or a Subsidiary, as the case may be. Such provisions shall be determined in the sole discretion of the Committee, need not be uniform among all Performance Units and may reflect distinctions based on reasons for termination of
employment or service. 
 10.7. Nontransferability. Except as otherwise determined by the Committee, Performance Units and
rights relating thereto may not be sold, transferred, pledged, assigned or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution. 

Article 11. Other Awards 
 11.1.
Grant of Other Awards. Subject to the terms and conditions of the Plan, Other Awards may be granted to Participants in such amounts, upon such terms, and at such times as the Committee shall determine. Types of Other Awards that may be
granted pursuant to this Article 11 include, without limitation, the payment of cash or Shares based on attainment of performance goals established by the Committee, the payment of Shares as a bonus or in lieu of cash based on attainment of
performance goals established by the Committee, and the payment of Shares in lieu of cash under other Company incentive or bonus programs. 

11.2. Payment of Other Awards. Payment under or settlement of any such Awards shall be made in such manner and at such times as
the Committee may determine. 
 11.3. Termination of Employment or Service. The Committee shall determine the extent to which
the Participant shall have the right to receive Other Awards following termination of the Participant’s employment or, if the Participant is a Director or Consultant, service with the Company and/or a Subsidiary, as the case may be. Such
provisions shall be determined in the sole discretion of the Committee, may be included in an agreement entered into with each Participant, but need not be uniform among all Other Awards, and may reflect distinctions based on the reasons for
termination of employment or service. 
 11.4. Nontransferability. Except as otherwise determined by the Committee, Other
Awards and rights relating thereto may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution. 

11.5. LLC Conversion Awards. The Committee shall be permitted to issue Other Awards under the Plan in the form of fully-vested
or restricted Shares in conversion of profits interest awards issued pursuant to the Black Knight Financial Services, LLC 2013 Management Incentive Plan and the Amended and Restated Limited Liability Company Agreement of Black Knight Financial
Services, LLC, which Awards shall be subject to such terms and conditions as determined by the Committee (“LLC Conversion Awards”). 

  
 15 

 Article 12. Replacement Awards 

Each Replacement Award shall have substantially the same terms and conditions (as determined by the Committee) as the award it replaces;
provided, however, that the number of Shares subject to Replacement Awards, the Exercise Price, grant price or other price of Shares subject to Replacement Awards, any performance conditions relating to Shares underlying Replacement Awards, or the
market price of Shares underlying Replacement Awards or per-Share results may differ from the awards they replace to the extent such differences are determined to be appropriate and equitable by the Committee, in its sole discretion. 

Article 13. Performance Measures 
 The
Committee may specify that the attainment of one or more of the performance measures set forth in this Article 13 shall determine the degree of granting, vesting and/or payout with respect to Awards (including any related dividends or Dividend
Equivalents) that the Committee intends will qualify for the Performance-Based Exception. The performance goals to be used for such Awards shall be chosen from among the following performance measure(s): earnings per share, economic value created,
market share (actual or targeted growth), net income (before or after taxes), operating income, earnings before interest, taxes, depreciation and amortization (EBITDA), earnings before interest, taxes, depreciation, amortization and restructuring
costs (EBITDAR), adjusted net income after capital charge, return on assets (actual or targeted growth), return on capital (actual or targeted growth), return on equity (actual or targeted growth), return on investment (actual or targeted growth),
revenue (actual or targeted growth), cash flow, operating margin, share price, share price growth, total stockholder return, and strategic business criteria consisting of one or more objectives based on meeting specified market penetration goals,
productivity measures, geographic business expansion goals, cost targets, customer satisfaction or employee satisfaction goals, goals relating to merger synergies, management of employment practices and employee benefits, or supervision of
litigation and information technology, and goals relating to acquisitions or divestitures of Subsidiaries and/or other affiliates or joint ventures. The targeted level or levels of performance with respect to such performance measures may be
established at such levels and on such terms as the Committee may determine, in its discretion, including in absolute terms, as a goal relative to performance in prior periods, or as a goal compared to the performance of one or more comparable
companies or an index covering multiple companies. Awards (including any related dividends or Dividend Equivalents) that are not intended to qualify for the Performance-Based Exception may be based on these or such other performance measures as the
Committee may determine. 
 Achievement of performance goals in respect of Awards intended to qualify under the Performance-Based Exception
shall be measured over a Performance Period, and the goals shall be established not later than ninety (90) days after the beginning of the 

  
 16 

 
Performance Period or, if less than (90) days, the number of days that is equal to twenty-five percent (25%) of the relevant Performance Period applicable to the Award. The Committee
shall have the discretion to adjust the determinations of the degree of attainment of the pre-established performance goals; provided, however, that Awards that are designed to qualify for the Performance-Based Exception may not be adjusted upward
(the Committee may, in its discretion, adjust such Awards downward). 
 Article 14. Beneficiary Designation 

Each Participant under the Plan may, from time to time, name any beneficiary or beneficiaries (who may be named contingently or successively)
to whom any benefit under the Plan is to be paid in case of his or her death before he or she receives any or all of such benefit. Each such designation shall revoke all prior designations by the same Participant, shall be in a form prescribed by
the Committee, and will be effective only when filed by the Participant in writing during the Participant’s lifetime with the Committee. In the absence of any such designation, benefits remaining unpaid at the Participant’s death shall be
paid to the Participant’s estate. 
 Article 15. Deferrals 

If permitted by the Committee, a Participant may defer receipt of amounts that would otherwise be provided to such Participant with respect to
an Award, including Shares deliverable upon exercise of an Option or SAR or upon payout of any other Award. If permitted, such deferral (and the required deferral election) shall be made in accordance with, and shall be subject to, the terms and
conditions of the applicable nonqualified deferred compensation plan, agreement or arrangement under which such deferral is made and such other terms and conditions as the Committee may prescribe. 

Article 16. Rights of Participants 
 16.1.
Continued Service. Nothing in the Plan shall: 
 (a) interfere with or limit in any way the right of the Company or a
Subsidiary to terminate any Participant’s employment or service at any time, 
 (b) confer upon any Participant any right to continue
in the employ or service of the Company or a Subsidiary, nor 
 (c) confer on any Director any right to continue to serve on the Board of
Directors of the Company or a Subsidiary. 
 16.2. Participation. No Employee, Director or Consultant shall have the right to
be selected to receive an Award under the Plan, or, having been so selected, to be selected to receive future Awards. 

  
 17 

 Article 17. Change in Control 

Except as otherwise provided in a Participant’s Award Agreement, upon the occurrence of a Change in Control, unless otherwise specifically
prohibited under applicable laws, or by the rules and regulations of any governing governmental agencies or national securities exchanges: 

(a) any and all outstanding Options and SARs granted hereunder shall become immediately exercisable; provided, however, that the Committee may
instead provide that such Awards shall be automatically cashed out upon a Change in Control; 
 (b) any Period of Restriction or other
restriction imposed on Restricted Stock, Restricted Stock Units and Other Awards shall lapse; and 
 (c) any and all Performance Shares,
Performance Units and other Awards (if performance-based) shall be deemed earned at the target level (or if no target level is specified, the maximum level) with respect to all open Performance Periods. 

Article 18. Additional Forfeiture Provisions 

The Committee may condition a Participant’s right to receive a grant of an Award, to vest in the Award, to exercise the Award, to retain
cash, Shares, other Awards, or other property acquired in connection with the Award, or to retain the profit or gain realized by the Participant in connection with the Award, including cash or other proceeds received upon sale of Shares acquired in
connection with an Award, upon compliance by the Participant with specified conditions relating to non-competition, confidentiality of information relating to or possessed by the Company, non-solicitation of customers, suppliers, and employees of
the Company, cooperation in litigation, non-disparagement of the Company and its officers, directors and affiliates, and other restrictions upon or covenants of the Participant, including during specified periods following termination of employment
with or service for the Company and/or a Subsidiary. 
 Article 19. Amendment, Modification, Termination, and Stockholder Approval 

19.1. Amendment, Modification, and Termination. The Board may at any time and from time to time, alter, amend, suspend or
terminate the Plan in whole or in part; provided, however, that no amendment that requires stockholder approval in order for the Plan to continue to comply with the New York Stock Exchange listing standards or any rule promulgated by the United
States Securities and Exchange Commission or any securities exchange on which the securities of the Company are listed shall be effective unless such amendment shall be approved by the requisite vote of stockholders of the Company entitled to vote
thereon within the time period required under such applicable listing standard or rule. Except as provided in Section 4.3 hereof, the Board does not have the power to amend the terms of previously granted options to reduce the exercise price
per share subject to such options, or to cancel such options and grant substitute options with a lower exercise price per share than the cancelled options. The Company is not permitted to purchase for cash previously granted options with an exercise
price that is greater than the Company’s trading price on the proposed date of purchase. 

  
 18 

 19.2. Adjustment of Awards Upon the Occurrence of Certain Unusual or Nonrecurring
Events. The Committee may make adjustments in the terms and conditions of, and the criteria included in, Awards in recognition of unusual or nonrecurring events (including, without limitation, the events described in Section 4.3 hereof)
affecting the Company or the financial statements of the Company or of changes in applicable laws, regulations, or accounting principles, whenever the Committee determines that such adjustments are appropriate in order to prevent dilution or
enlargement of the benefits or potential benefits intended to be made available under the Plan; provided, however, that (except as provided in Section 4.3 hereof) the Committee does not have the power to amend the terms of previously granted
options to reduce the exercise price per share subject to such options, or to cancel such options and grant substitute options with a lower exercise price per share than the cancelled options. The Company is not permitted to purchase for cash
previously granted options with an exercise price that is greater than the Company’s trading price on the proposed date of purchase. With respect to any Awards intended to comply with the Performance-Based Exception, any such exception shall be
specified at such times and in such manner as will not cause such Awards to fail to qualify under the Performance-Based Exception. 
 19.3.
Awards Previously Granted. No termination, amendment or modification of the Plan or of any Award shall adversely affect in any material way any Award previously granted under the Plan without the written consent of the Participant
holding such Award, unless such termination, modification or amendment is required by applicable law and except as otherwise provided herein. 

19.4. Compliance with the Performance-Based Exception. If it is intended that an Award (and/or any dividends or Dividend
Equivalents relating to such Award) comply with the requirements of the Performance-Based Exception, the Committee may apply any restrictions it deems appropriate such that the Awards (and/or dividends or Dividend Equivalents) maintain eligibility
for the Performance-Based Exception. If changes are made to Code Section 162(m) or regulations promulgated thereunder to permit greater flexibility with respect to any Award or Awards available under the Plan, the Committee may, subject to this
Article 19, make any adjustments to the Plan and/or Award Agreements it deems appropriate. 
 19.5. Stockholder Approval. For
purposes of compliance with Code Section 162(m), the Company shall, to the extent it deems necessary, submit the Plan for approval by the Company’s stockholders at the first annual meeting that occurs more than 12 months after the date the
Company becomes a “separate publicly held corporation”, within the meaning of Treas. Reg. Section 1.162-27(f)(4). 
 Article 20.
Withholding 
 20.1. Tax Withholding. The Company shall have the power and the right to deduct or withhold, or require a
Participant to remit to the Company, an amount sufficient to satisfy federal, state, local, domestic or foreign taxes required by law or regulation to be withheld with respect to any taxable event arising as a result of the Plan. 

  
 19 

 20.2. Use of Shares to Satisfy Withholding Obligation. With respect to withholding
required upon the exercise of Options or SARs, upon the vesting or settlement of Restricted Stock, Restricted Stock Units, Performance Shares or Performance Units, or upon any other taxable event arising as a result of Awards granted hereunder, the
Committee may require or may permit Participants to elect that the withholding requirement be satisfied, in whole or in part, by having the Company withhold, or by tendering to the Company, Shares having a Fair Market Value equal to the minimum
statutory withholding (based on minimum statutory withholding rates for federal and state tax purposes, including payroll taxes) that could be imposed on the transaction and, in any case in which it would not result in additional accounting expense
to the Company, taxes in excess of the minimum statutory withholding amounts. Any such elections by a Participant shall be irrevocable, made in writing and signed by the Participant. 

Article 21. Indemnification 
 Each person
who is or shall have been a member of the Committee, or of the Board, shall be indemnified and held harmless by the Company to the fullest extent permitted by Delaware law against and from any loss, cost, liability, or expense that may be imposed
upon or reasonably incurred by him or her in connection with or resulting from any claim, action, suit, or proceeding to which he or she may be a party or in which he or she may be involved by reason of any action taken or failure to act under the
Plan and against and from any and all amounts paid by him or her in settlement thereof, with the Company’s approval, or paid by him or her in satisfaction of any judgment in any such action, suit, or proceeding against him or her, provided he
or she shall give the Company an opportunity, at its own expense, to handle and defend the same before he or she undertakes to handle and defend it on his or her own behalf. The foregoing right of indemnification is subject to the person having been
successful in the legal proceedings or having acted in good faith and what is reasonably believed to be a lawful manner in the Company’s best interests. The foregoing right of indemnification shall not be exclusive of any other rights of
indemnification to which such persons may be entitled under the Company’s Certificate of Incorporation or Bylaws, as a matter of law, or otherwise, or any power that the Company may have to indemnify them or hold them harmless. 

Article 22. Successors 
 All obligations
of the Company under the Plan and with respect to Awards shall be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or other event, or a sale or
disposition of all or substantially all of the business and/or assets of the Company. 

  
 20 

 Article 23. Limitation on Dividends and Dividend Equivalents 

Notwithstanding anything in this Plan to the contrary, if dividends or Dividend Equivalents are granted with respect to any Awards that are
subject to performance-based vesting conditions, the dividends or Dividend Equivalents shall be accumulated or reinvested and paid only after such performance-based vesting conditions are met, as set forth by the Committee in the applicable Award
Agreement. 
 Article 24. Minimum Vesting Period 

Awards under the Plan generally will not contain vesting schedules that provide for vesting to occur more quickly than ratably over two years;
provided, however, that this minimum vesting requirement may be waived in extraordinary circumstances, shall not apply to Other Awards granted under Section 11.5, and shall not prevent Awards from vesting upon death or disability, termination
of service as an Employee, Director or Consultant, or a Change in Control. 
 Article 25. Legal Construction 

25.1. Gender, Number and References. Except where otherwise indicated by the context, any masculine term used herein also shall
include the feminine; the plural shall include the singular and the singular shall include the plural. Any reference in the Plan to an act or code or to any section thereof or rule or regulation thereunder shall be deemed to refer to such act, code,
section, rule or regulation, as may be amended from time to time, or to any successor act, code, section, rule or regulation. 
 25.2.
Severability. In the event any provision of the Plan shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining parts of the Plan, and the Plan shall be construed and enforced as if the
illegal or invalid provision had not been included. 
 25.3. Requirements of Law. The granting of Awards and the issuance of
Shares under the Plan shall be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required. 

25.4. Governing Law. To the extent not preempted by federal law, the Plan, and all agreements hereunder, shall be construed in
accordance with and governed by the laws of the State of Florida, without giving effect to conflicts or choice of law principles. 
 25.5.
Non-Exclusive Plan. Neither the adoption of the Plan by the Board nor its submission to the stockholders of the Company for approval shall be construed as creating any limitations on the power of the Board or a committee thereof to
adopt such other incentive arrangements as it may deem desirable, including other incentive arrangements and awards that do or do not qualify under the Performance-Based Exception. 

  
 21 

 25.6. Code Section 409A Compliance. To the extent applicable, it is intended
that this Plan and any Awards granted under the Plan comply with the requirements of Code Section 409A and any related regulations or other guidance promulgated with respect to such Section by the U.S. Department of the Treasury or the Internal
Revenue Service (collectively “Section 409A”). Any provision that would cause the Plan or any Award granted under the Plan to fail to satisfy Section 409A shall have no force or effect until amended to comply with Section 409A,
which amendment may be retroactive to the extent permitted by Section 409A. 

  
 22

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00245-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00245-of-00352.parquet"}]]